Experimental oncology

Chronic Lymphocytic Leukemia


Head physician

Paolo Ghia


The research activity of the Unit aims at translating basic biological and molecular findings to the clinical arena, to the advantage of patients affected by Chronic Lymphocytic Leukemia (CLL).

Research activity

In particular, our Unit works towards the validation and application of novel prognostic and predictive markers that can improve the management of our patients and allow the selection of more tailored therapies when needed. In addition, we design and participate in innovative clinical trials testing novel chemo-free therapeutic approaches, from the initial stages of development (phase 1) to the final validation before the introduction in the general practice (phase 3).

Finally, we are greatly involved in educational activities of the medical community with the aim of disseminating the best practice in terms of molecular stratification of patients, selection of personalized treatments and management of adverse reactions with the final goal of achieving more prolonged responses and higher quality of life.